JP

Minoru Okada

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minoru Okada. Retrieved from https://idiyas.com/inventor/minoru-okada-2mteqwgv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Minoru Okada: Innovator in Pharmaceutical Chemistry

Introduction

Minoru Okada is a notable inventor in the field of pharmaceutical chemistry. He has contributed to the development of innovative compounds and compositions aimed at addressing various medical conditions. His work reflects a commitment to advancing healthcare through scientific research and invention.

Latest Patents

Minoru Okada holds several patents, including an oxazole compound and a pharmaceutical composition. The oxazole compound is represented by a specific formula and exhibits a unique inhibitory action against phosphodiesterase 4. Additionally, he has developed a composition for the treatment of chronic venous insufficiencies, which combines an extract of red vine leaves with an anti-inflammatory agent. This composition aims to alleviate discomfort associated with mild-to-moderate chronic venous insufficiency of the legs.

Career Highlights

Throughout his career, Minoru Okada has worked with various companies, including Kenji Masuda and Kazuki Matsumoto. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Minoru Okada has collaborated with several professionals in his field, including Masaya Kato and Norifumi Sato. These collaborations have fostered a productive environment for innovation and development in pharmaceutical chemistry.

Conclusion

Minoru Okada's contributions to pharmaceutical chemistry demonstrate his dedication to improving healthcare through innovative inventions. His work continues to influence the field and offers promising solutions for medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…